Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Cytokinetics, Incorporated (CYTK)

« Back to company index

CYTK Chatter Timeline

Stock Ticker for CYTK

Most Active Tweeters for CYTK

UserTweets
@Tickeron 8
@AmericanBanking 4
@OlympiaReport 4
@ThisLincolnian 3
@WeekHerald 3

Recent Tweets for CYTK

AmericanBanking @AmericanBanking
Robert I. Blum Sells 6,000 Shares of Cytokinetics, Inc. $CYTK Stock https://t.co/Yw8OVYFkw4 #stocks
September 17th 2019, 5:09pm
fintel_io @fintel_io
Insider Blum Robert I reports selling 6,000 shares of $CYTK for a total cost of $76,469.40 (CLICK TO SEE TRADING P… https://t.co/UYZa7DxWuA
September 17th 2019, 5:09pm
InsiderAlertsIA @InsiderAlertsIA
$CYTK: New Insider Filing on President & CEO ROBERT I BLUM: https://t.co/LYsn5vWCjz
September 17th 2019, 5:09pm
stocknewstimes @stocknewstimes
Cytokinetics $CYTK Given a $23.00 Price Target at JMP Securities https://t.co/hLZxiWTU58
September 17th 2019, 3:09am
TranscriptDaily @TranscriptDaily
Cytokinetics $CYTK Given a $23.00 Price Target at JMP Securities https://t.co/TVEjzc0zS9
September 17th 2019, 3:09am
TheMarketsDaily @TheMarketsDaily
Cytokinetics $CYTK Given a $23.00 Price Target at JMP Securities https://t.co/J8ckw2YFfJ
September 17th 2019, 3:09am
Tickeron @Tickeron
$CYTK in Uptrend: 50-day Moving Average moved above 200-day Moving Average on April 10, 2019. View odds for this an… https://t.co/IB1ZghZ3Xc
September 16th 2019, 11:09pm
Gambiste1 @Gambiste1
RT @AlexBo6: @IlliniJJ did you miss $CYTK , huge amount of data to consume , but no improvement in earnings ..a bitter pill
September 16th 2019, 6:09pm
AlexBo6 @AlexBo6
@IlliniJJ did you miss $CYTK , huge amount of data to consume , but no improvement in earnings ..a bitter pill
September 16th 2019, 4:09pm
MarketCurrents @MarketCurrents
$CYTK - Cytokinetics up 4% on positive early-stage data on CK-274 https://t.co/stsxqv19cW
September 16th 2019, 12:09pm
biostockinfo @biostockinfo
RT @InsiderBiotech: $CYTK CYTOKINETICS ANNOUNCES DATA FROM PHASE 1 STUDY OF CK-3773274 The study met its primary and secondary objectives t…
September 16th 2019, 9:09am
InsiderBiotech @InsiderBiotech
$CYTK CYTOKINETICS ANNOUNCES DATA FROM PHASE 1 STUDY OF CK-3773274 The study met its primary and secondary objectiv… https://t.co/pCRawhLJYo
September 16th 2019, 9:09am
syinvesting @syinvesting
$CYTK announced positive data from the Ph 1 study of CK-274 in oHCM. These data support the advancement of CK-274 i… https://t.co/mFxQuzs4eZ
September 16th 2019, 9:09am
VisualStockRSRC @VisualStockRSRC
$CYTK - Cytokinetics Announces Data From Phase 1 Study of CK-3773274 at the HFSA 23?? Annual Scientific https://t.co/XHXEdWsWTm
September 16th 2019, 7:09am
TickerReport @TickerReport
JMP Securities Raises Cytokinetics $CYTK Price Target to $23.00 https://t.co/XWfH9a6a7y
September 16th 2019, 5:09am
TickerReport @TickerReport
Zacks Investment Research Upgrades Cytokinetics $CYTK to “Hold” https://t.co/VeHsNaib1I
September 16th 2019, 2:09am
AmericanBanking @AmericanBanking
Cytokinetics $CYTK – Analysts’ Weekly Ratings Updates https://t.co/407fLeimYC #stocks
September 16th 2019, 2:09am
dailypoliticaln @dailypoliticaln
Cytokinetics $CYTK Given New $23.00 Price Target at JMP Securities https://t.co/SLtillUwFo
September 14th 2019, 3:09pm
ZolmaxNews @ZolmaxNews
Cytokinetics $CYTK Given New $23.00 Price Target at JMP Securities https://t.co/ZZwhRtNQJE
September 14th 2019, 3:09pm
WatchlistN @WatchlistN
Cytokinetics $CYTK Given New $23.00 Price Target at JMP Securities https://t.co/1OXT0ilRha
September 14th 2019, 3:09pm
Tickeron @Tickeron
$CYTK in Uptrend: 50-day Moving Average moved above 200-day Moving Average on April 10, 2019. View odds for this an… https://t.co/kBc00pkxSS
September 14th 2019, 1:09am
dakotafinancial @dakotafinancial
Traders Purchase Large Volume of Cytokinetics Put Options $CYTK https://t.co/sL7MKypEYf
September 13th 2019, 11:09pm
AmericanBanking @AmericanBanking
Cytokinetics Target of Unusually High Options Trading $CYTK https://t.co/ZQ4N2s4AyD #stocks
September 13th 2019, 5:09pm
OlympiaReport @OlympiaReport
Cytokinetics Target of Unusually High Options Trading $CYTK https://t.co/784TpqETd6
September 13th 2019, 5:09pm
WeekHerald @WeekHerald
Cytokinetics Target of Unusually High Options Trading $CYTK https://t.co/bEllNGiXg4
September 13th 2019, 5:09pm
ThisLincolnian @ThisLincolnian
Cytokinetics Target of Unusually High Options Trading $CYTK https://t.co/sFyU76PCMi
September 13th 2019, 5:09pm
grostz @grostz
$CYTK looks like a badly managed version of $MYOK. Science is good, but they made some very bad decisions, like goi… https://t.co/MXt6pBa28B
September 13th 2019, 3:09pm
WeekHerald @WeekHerald
Cytokinetics $CYTK Upgraded by Zacks Investment Research to Hold https://t.co/xWh3LZjNTt
September 13th 2019, 1:09pm
OlympiaReport @OlympiaReport
Cytokinetics $CYTK Raised to Hold at Zacks Investment Research https://t.co/4StlSdFcKz
September 13th 2019, 1:09pm
dispatchtribune @dispatchtribune
Cytokinetics $CYTK Upgraded by Zacks Investment Research to Hold https://t.co/OgrYfiOZSe
September 13th 2019, 1:09pm
AmericanBanking @AmericanBanking
Cytokinetics $CYTK Given New $23.00 Price Target at JMP Securities https://t.co/amGQWacAdS #stocks
September 13th 2019, 8:09am
Quantumup1 @Quantumup1
$CYTK PT raised to $23, keeps a Buy rating at JMP Securities https://t.co/0Jf9KNVFXP
September 13th 2019, 7:09am
Tickeron @Tickeron
$CYTK in Uptrend: 50-day Moving Average crossed above 200-day Moving Average on April 10, 2019. View odds for this… https://t.co/diGDxrRP0n
September 12th 2019, 10:09pm
bbnsnews @bbnsnews
Cytokinetics $CYTK Upgraded to Hold by Zacks Investment Research https://t.co/9TmKWLof4O
September 12th 2019, 9:09pm
MC_OptionTrades @MC_OptionTrades
$CYTK 20-Sep-19 Straddle Implies a ±7.6% move. Sep 13 23rd Annual HFSA Scientific Meeting https://t.co/RAQCvG1R6t
September 12th 2019, 4:09pm
Tickeron @Tickeron
$CYTK in Uptrend: 50-day Moving Average broke above 200-day Moving Average on April 10, 2019. View odds for this an… https://t.co/tBacPgWRCR
September 11th 2019, 11:09pm
Tickeron @Tickeron
$CYTK in Uptrend: 50-day Moving Average crossed above 200-day Moving Average on April 10, 2019. View odds for this… https://t.co/ArQ6v23qx2
September 10th 2019, 10:09pm
TranscriptDaily @TranscriptDaily
Cytokinetics’ $CYTK “Overweight” Rating Reiterated at Cantor Fitzgerald https://t.co/NslkI6DpcE
September 10th 2019, 5:09am
Tickeron @Tickeron
$CYTK in Uptrend: 50-day Moving Average crossed above 200-day Moving Average on April 10, 2019. View odds for this… https://t.co/5HPyeFOLIM
September 9th 2019, 9:09pm
Cytokinetics @Cytokinetics
$CYTK investors: Today our CEO Robert Blum presented at the Morgan Stanley Healthcare Conference. Tomorrow he will… https://t.co/TvpebbCUw3
September 9th 2019, 3:09pm
IlliniJJ @IlliniJJ
$CYTK - looks like some folks jumping off ahead of data.
September 9th 2019, 1:09pm
AlertTrade @AlertTrade
TREND REVERSAL DOWN ALERT: $CYTK Cytokinetics, Inc ? TradeIdeas via https://t.co/VS8RO1bzXJ to FREE Trading Room
September 9th 2019, 11:09am
Tickeron @Tickeron
$CYTK in Uptrend: 50-day Moving Average broke above 200-day Moving Average on April 10, 2019. View odds for this an… https://t.co/j4OZxGxlYv
September 8th 2019, 8:09pm
ConsumerFeed @ConsumerFeed
Cantor Fitzgerald Reaffirms “Overweight” Rating for Cytokinetics $CYTK https://t.co/xGFWr2hlQr
September 8th 2019, 12:09pm
TickerReport @TickerReport
Cytokinetics $CYTK Stock Rating Reaffirmed by Cantor Fitzgerald https://t.co/gV9ztSewCl
September 8th 2019, 12:09pm
OlympiaReport @OlympiaReport
Cytokinetics $CYTK Upgraded at Zacks Investment Research https://t.co/Unj4NeETqe
September 8th 2019, 12:09pm
WeekHerald @WeekHerald
Cytokinetics $CYTK Upgraded at Zacks Investment Research https://t.co/NoKP1fgXWT
September 8th 2019, 12:09pm
ThisLincolnian @ThisLincolnian
Cytokinetics $CYTK Upgraded at Zacks Investment Research https://t.co/aVh34II4DS
September 8th 2019, 11:09am
Tickeron @Tickeron
$CYTK in Uptrend: 50-day Moving Average crossed above 200-day Moving Average on April 10, 2019. View odds for this… https://t.co/xzJ8Y1OeoS
September 7th 2019, 9:09pm
OlympiaReport @OlympiaReport
Cytokinetics $CYTK Given Overweight Rating at Cantor Fitzgerald https://t.co/a9EDpLJH3N
September 7th 2019, 11:09am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.